The overall goal of this proposal is to investigate translational and posttranslational control of the c-myc and """"""""activated"""""""" myc proteins during growth. Based on preliminary studies, the hypothesis is that a factor(s) in the conditioned media induces the non-AUG initiation of c-myc 1 protein through the modification of a protein(s) in the translational initiation complex which then efficiently recognizes the non-AUG codon. These ideas will be tested by 1) characterizing the biochemical nature and specificity of the factor(s) in conditioned media which induces c-myc 1, 2) examining the changes in proteins associated with the translational initiation complex during c-myc 1 induction by two-dimensional gels and RNA-protein UV crosslinking and 3) determining the influence of sequence and secondary structure on the basal and induced levels of non-AUG initiation by translating c-myc in vitro and in vivo after site-directed mutagenesis. In addition, the posttranslational control of c-myc will be investigated by the further characterization of three recently identified phosphorylation sites in a highly conserved region of the N-terminal domain of c-myc. Based on preliminary studies, these phosphorylation events may be controlled by cell cycle and/or growth-regulated processes and may modulate the biological function of c-myc in growth control. These ideas will be tested by 1) determining if myc proteins are substrates for cdc 2 kinase Ix vivo by assaying the kinase activity of the cdc 2 complex immunoprecipitated from normal and transformed cells in different phases of the cell cycle using myc Hl histone and casein proteins as substrates, 2) characterizing the kinase which phosphorylates c-myc protein at the threonine which. is absent in v-myc proteins by determining if growth changes modulate the phosphorylation of this site and examining the properties of this kinase using a myc peptide as a substrate in vitro, 3) determining the influence of phosphorylation of the c-myc N-terminal domain on biological function by overexpressing mutants containing nonphosphorylatable residues in 1OT1/2 cells and measuring their ability to grow in .semisolid media. These studies will not only provide valuable information on the control of normal c-myc proteins in growth control and the activation of c-myc proteins associated with transformation and tumorigenesis, but will also provide information on the basic processes of translational and posttranslational regulation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047399-05
Application #
3191032
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1988-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Vaknin, Uri A; Hann, Stephen R (2006) The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic. J Cell Biochem 97:1094-103
Hsia, Nelson; Brousal, Jeffrey P; Hann, Stephen R et al. (2005) Recapitulation of germ cell- and pituitary-specific expression with 1.6 kb of the cystatin-related epididymal spermatogenic (Cres) gene promoter in transgenic mice. J Androl 26:249-57
Gregory, Mark A; Qi, Ying; Hann, Stephen R (2005) The ARF tumor suppressor: keeping Myc on a leash. Cell Cycle 4:249-52
Gregory, Mark A; Qi, Ying; Hann, Stephen R (2003) Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606-12
Cornwall, G A; Collis, R; Xiao, Q et al. (2001) B-Myc, a proximal caput epididymal protein, is dependent on androgens and testicular factors for expression. Biol Reprod 64:1600-7
Gregory, M A; Hann, S R (2000) c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 20:2423-35
Claassen, G F; Hann, S R (2000) A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc Natl Acad Sci U S A 97:9498-503
Gregory, M A; Xiao, Q; Cornwall, G A et al. (2000) B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene 19:4886-95
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Spotts, G D; Patel, S V; Xiao, Q et al. (1997) Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17:1459-68

Showing the most recent 10 out of 23 publications